Caseys General Stores Inc's fundamentals are relatively stable, with industry-average ESG disclosure.and its growth potential is significant.Its valuation is considered fairly valued, ranking 16 out of 30 in the Food & Drug Retailing industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 639.09.In the medium term, the stock price is expected to trend up.Despite a good stock market performance and strong technicals over the past month, the fundamentals don't support the current trend.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Media Coverage
The current financial score of Caseys General Stores Inc is 5.46, ranking 27 out of 30 in the Food & Drug Retailing industry. Its financial status is weak, and its operating efficiency is low. Its latest quarterly revenue reached 4.51B, representing a year-over-year increase of 14.17%, while its net profit experienced a year-over-year increase of 14.05%.
The current valuation score of Caseys General Stores Inc is 5.42, ranking 28 out of 30 in the Food & Drug Retailing industry. Its current P/E ratio is 37.40, which is 4.76% below the recent high of 39.18 and 54.51% above the recent low of 17.01.

The current earnings forecast score of Caseys General Stores Inc is 7.78, ranking 11 out of 30 in the Food & Drug Retailing industry. The average price target is 600.00, with a high of 700.00 and a low of 465.25.


Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
The current price momentum score of Caseys General Stores Inc is 9.05, ranking 8 out of 30 in the Food & Drug Retailing industry. Currently, the stock price is trading between the resistance level at 655.74 and the support level at 559.16, making it suitable for range-bound swing trading.

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
The current institutional shareholding score of Caseys General Stores Inc is 10.00, ranking 1 out of 30 in the Food & Drug Retailing industry. The latest institutional shareholding proportion is 93.63%, representing a quarter-over-quarter decrease of 0.57%. The largest institutional shareholder is The Vanguard, holding a total of 3.75M shares, representing 10.11% of shares outstanding, with 0.61% decrease in holdings.

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Food & Drug Retailing domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. No risk assessment score is currently available for Caseys General Stores Inc. The Food & Drug Retailing industry's average is 5.55. The company's beta value is 0.68. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. Caseys General Stores Inc’s latest ESG disclosure is at an average level in the Food & Drug Retailing industry, showing no material impact on overall risk.